01 3Gowling WLG
02 30Gowling WLG (Canada) LLP
01 11341082
02 12226575
03 12311409
04 22376596
05 12407556
06 22490758
07 32540547
08 42574821
09 22579861
10 22596133
11 42711798
12 22768458
13 42788253
14 22907776
15 23047349
01 7Pertuzumab
02 26Pertuzumab | Trastuzumab
01 14SOLUTION
02 7Solution
03 12solution , powder for solution
01 12016-07-23
02 12017-08-08
03 12018-12-10
04 22020-06-23
05 12021-05-18
06 22023-07-11
07 42025-07-15
08 22025-10-19
09 22026-02-21
10 32026-03-21
11 42029-01-28
12 22030-07-28
13 42032-08-29
14 22034-04-15
15 22038-01-16
Patent Expiration Date : 2020-06-23
Date Granted : 2009-10-06
Brand Name : PERJETA
Patent Number : 2376596
Filing Date : 2000-06-23
Strength per Unit : 420mg / 14mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-06-23
Date Granted : 2009-10-06
Patent Expiration Date : 2025-10-19
Date Granted : 2012-12-18
Brand Name : PERJETA
Patent Number : 2579861
Filing Date : 2005-10-19
Strength per Unit : 420mg / 14mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2025-10-19
Date Granted : 2012-12-18
Patent Expiration Date : 2025-07-15
Date Granted : 2013-07-09
Brand Name : PERJETA
Patent Number : 2574821
Filing Date : 2005-07-15
Strength per Unit : 420mg / 14mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2025-07-15
Date Granted : 2013-07-09
Patent Expiration Date : 2029-01-28
Date Granted : 2014-05-06
Brand Name : PERJETA
Patent Number : 2711798
Filing Date : 2009-01-28
Strength per Unit : 420mg / 14mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2029-01-28
Date Granted : 2014-05-06
Patent Expiration Date : 2023-07-11
Date Granted : 2014-09-23
Brand Name : PERJETA
Patent Number : 2490758
Filing Date : 2003-07-11
Strength per Unit : 420mg / 14mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2023-07-11
Date Granted : 2014-09-23
Patent Expiration Date : 2025-10-19
Date Granted : 2012-12-18
Brand Name : PERJETA HERCEPTIN COMBO PACK
Patent Number : 2579861
Filing Date : 2005-10-19
Strength per Unit : 420mg / 14mL , 440mg / vial
Dosage Form : solution , powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2025-10-19
Date Granted : 2012-12-18
Patent Expiration Date : 2018-12-10
Date Granted : 2011-04-12
Brand Name : PERJETA HERCEPTIN COMBO PACK
Patent Number : 2311409
Filing Date : 1998-12-10
Strength per Unit : 420mg / 14mL , 440mg / vial
Dosage Form : solution , powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2018-12-10
Date Granted : 2011-04-12
Patent Expiration Date : 2016-07-23
Date Granted : 2011-10-18
Brand Name : PERJETA HERCEPTIN COMBO PACK
Patent Number : 2226575
Filing Date : 1996-07-23
Strength per Unit : 420mg / 14mL , 440mg / vial
Dosage Form : solution , powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2016-07-23
Date Granted : 2011-10-18
Patent Expiration Date : 2017-08-08
Date Granted : 2000-08-08
Brand Name : PERJETA HERCEPTIN COMBO PACK
Patent Number : 1341082
Filing Date : 1989-01-12
Strength per Unit : 420mg / 14mL , 440mg / vial
Dosage Form : solution , powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2017-08-08
Date Granted : 2000-08-08
Patent Expiration Date : 2020-06-23
Date Granted : 2009-10-06
Brand Name : PERJETA HERCEPTIN COMBO PACK
Patent Number : 2376596
Filing Date : 2000-06-23
Strength per Unit : 420mg / 14mL , 440mg / vial
Dosage Form : solution , powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-06-23
Date Granted : 2009-10-06
